I am a breast oncologist at Houston Methodist Neal Cancer Center. I earned my medical degree from Qingdao Medical School in China. I completed my residency training in internal medicine and fellowship training in hematology and oncology at Houston Methodist Hospital.  My main clinical focus is on solid tumor oncology, with a special focus on breast cancer. As a clinical investigator, my clinical research aims to evaluate novel biologic agents in breast cancer patients.  I have particular interest in immunotherapy and triple negative breast cancer (TNBC). My research focuses on characterizing the tumor microenvironment in obesity-related TNBC and targeting inflammatory pathways to alter the tumor immune microenvironment.

I am a Burrough's Wellcome Fund Scholar. Some of the awards I received include the Conquer Cancer Merit Award, being selected to attend the 2021 AACR/ASCO Workshop on Methods in Clinical Cancer Research and 2022 Conquer Cancer Young Investigator Award. I am an active member of American Society of Clinical Oncology, American Society of Hematology, American Association for Cancer Research and Academy of Physicians in Clinical Research.